London, 20 March.
According to the study, women are less likely to receive life-saving treatment for cardiogenic shock than men and are therefore more at risk of death.
Cardiogenic shock is a life-threatening condition in which the heart suddenly stops pumping enough blood to supply the body’s organs with enough oxygen.
It is usually caused by a massive heart attack. It is estimated that 10% of patients with heart attacks affecting most of the heart also develop cardiogenic shock.
Only half of patients with cardiogenic shock survive.
Researchers at the Copenhagen University Hospital in Denmark showed that significantly fewer women received mechanical circulatory support (19 percent of women compared to 26 percent of men), minimally invasive or surgical procedures to restore blood flow in blocked arteries (83 percent of women compared to 88 percent of men). percent of women). men) and mechanical ventilation (67% of women versus 82% of men).
Thus, women were less likely to survive in the short and long term than men. At 30 days after a heart attack, only 38% of women were alive compared to 50% of men.
At 8.5 years of age, 27 percent of women were alive compared to 39 percent of men.
“There is growing evidence that women with acute heart problems are more likely than men to experience non-specific symptoms such as shortness of breath, nausea, vomiting, cough, fatigue, and pain in the back, jaw or neck,” the doctor said. Sarah Hall from the university.
“Better recognition that women may have symptoms other than chest pain could minimize delays in diagnosis and treatment and potentially improve prognosis,” she added.
The results were presented at ESC Acute CardioVascular Care 2022, the scientific congress of the European Society of Cardiology (ESC).
A total of 1716 patients with heart attack and cardiogenic shock were included in the study, of which 438 (26%) were women. The median age for women was 71, compared with 66 for men.
“The results suggest that raising healthcare professionals’ awareness that women have heart attacks and may develop cardiogenic shock could be a step towards fairer treatment and outcomes,” Holle said.